Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02348476 · ClinicalTrials.gov registry record
A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
A clinical trial, sponsored by Allergan.
- Completed
- Registry status
- 150
- Enrollment target
NCT02348476 is a clinical trial that has completed, run by Allergan. The registered enrollment target is 150 participants.
The verdict
NCT02348476 has completed, sponsored by Allergan.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
This study is a retrospective chart review to assess the tolerability and efficacy of treatment with Simbrinza™ used for patients with Open-Angle Glaucoma or Ocular Hypertension.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2014-11 |
| Est. Completion | 2015-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02348476
The ClinicalTrials.gov registry entry for NCT02348476 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allergan, which has 314 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT02348476 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02348476 about?
NCT02348476 is a clinical study titled "A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension". This study is a retrospective chart review to assess the tolerability and efficacy of treatment with Simbrinza™ used for patients with Open-Angle Glaucoma or Ocular Hypertension.
What is the current status of trial NCT02348476?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2014-11. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02348476?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT02348476?
This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.